MetLife, Inc.METNYSE
Loading
EBITDA Over TimeContracting
Percentile Rank21
3Y CAGR-10.5%
5Y CAGR-7.5%
Year-over-Year Change
Earnings before interest, taxes, depreciation, and amortization
3Y CAGR
-10.5%/yr
vs -0.3%/yr prior
5Y CAGR
-7.5%/yr
Consistent
Acceleration
-10.2pp
Decelerating
Percentile
P21
Within normal range
vs 5Y Ago
0.7x
Contraction
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $5.72B | -22.4% |
| 2024 | $7.37B | +87.8% |
| 2023 | $3.92B | -50.8% |
| 2022 | $7.97B | -21.3% |
| 2021 | $10.13B | +19.8% |
| 2020 | $8.46B | +0.9% |
| 2019 | $8.38B | +4.0% |
| 2018 | $8.06B | +47.6% |
| 2017 | $5.46B | -10.3% |
| 2016 | $6.09B | - |